Home Up Feedback Contents Search Sell your Prod. Meet us News           

 
Home • Up

Assay Designs

 

Home

GENTAUR

+32 1658 9045

or

0032 (0)16 41 44 07

+32 1650 9045

[email protected]

Av. de l' Armée 68

B-1040 Brussels

BELGIUM

France

tel 01 43 25 01 50

fax01 43 25 01 60

9, rue Lagrange

75005 Paris

Italia

tel 02 36 00 65 93

fax 02 36 00 65 94

20135 Milano

Deutschland

tel +32 1658 9045

fax +32 1650 9045

Polska

Tel 058 710 33 44

Fax 00 32 16 50 90 45

ul. Grunwaldzka 88A/2

81-771 Sopot

日本

tel +81 78 386 0860

fax +81 78 306 0296

Minaatojimaminami-manchi

Chuo-ku, Kobe

065-0047

Österreich
+43720880899

Canada Montreal
+15149077481

Česká republika Praha
+420246019719

Danmark
+4569918806

Finland Helsset
+358942419041

Ελλάς Αθήνα
+302111768494

Magyarország Budapest
+3619980547

Ireland Dublin
+35316526556

Luxembourg
+35220880274

Nederland
+31208080893

Norge Oslo
+4721031366

Polska Warszawa
+48223988221

Sverige Stockholm
+46852503438

Schweiz Züri
+41435006251

US New York
+17185132983

Other Countries
0032 (0)16 41 44 07


 

 

 

 

 

Product Launch

Osteopontin (rodent) EIA Kit

 

Assay Designs™ is happy to announce the launch of a ready-to-use enzyme immunoassay kit for the measurement of Osteopontin culture supernates, EDTA plasma, and urine samples from mouse and rat origins. 

Assay Performance Specifications

Catalog Number

900-090A

Standard Range

3.13 – 100 ng/mL

Sensitivity

3.03 ng/mL

Sample Types

culture supernates, EDTA plasma, and urine

Number of Samples

40 in duplicate

Time to Answer

3 hours

Species Reactivity

mouse & rat

Size

1 x 96 well

 Osteopontin (OPN) is an acidic extracellular matrix cell adhesion protein that is relatively abundant not only in bone matrix, plasma, urine, and milk, but is also found in malignant and atherogenic tissues. Phosphorylation, glycosylation and calcium modifications allow intact and fragmented Osteopontin to direct a variety of diverse responses including tissue remodeling, inflammation and cell survival. Plasma Osteopontin has been shown to be a positive indicator of colon and lung cancers as well as metastatic carcinomas. The notable presence of Osteopontin in a variety of tumors is strongly correlated to pathological stage, suggesting its critical role in tumor invasiveness, progression and metastasis. In addition, Osteopontin inhibits inducible nitric oxide synthase activity, thereby protecting tumor cells from NO-mediated macrophage cytotoxic attack. Osteopontin is found in atherosclerotic plaques and may drive a number of diabetic vascular pathologies.

 

Product Features & Benefits

  • Accurate – parallelism data demonstrates the recombinant standard accurately reflects natural osteopontin
  • Fast – results from up to 40 samples in duplicate in just 3 hours
  • Easy-to-use – color-coded reagents reduce error
  • Convenient – ready-to-use reagents and pre-coated 96-well plate

 

Copyright © 2002 GENTAUR Molecular Products
Last modified: 05/29/09